We are live on ! Find out more
SCV

Sands Capital Ventures Portfolio holdings

AUM $614M
1-Year Est. Return 19.92%
This Fund
S&P 500
This Quarter Est. Return
+44%
1 Year Est. Return
+19.92%
3 Year Est. Return
+166.76%
5 Year Est. Return
+157.76%
10 Year Est. Return
–
AUM
$359M
AUM Growth
+$21.4M
Cap. Flow
-$61.6M
Cap. Flow %
-17.13%
Top 10 Hldgs %
97.67%
Holding
23
New
–
Increased
5
Reduced
6
Closed
2

Top Buys

Rank Stock Value
1
KVYO icon
Klaviyo
KVYO
+$54.1K
2
CPNG icon
Coupang
CPNG
+$33.2K
3
NU icon
Nu Holdings
NU
+$25.2K
4
TOST icon
Toast
TOST
+$12.2K
5
SNOW icon
Snowflake
SNOW
+$7.44K

Top Sells

Rank Stock Value
1
IOT icon
Samsara
IOT
+$25.9M
2
PATH icon
UiPath
PATH
+$14.9M
3
OLK
Olink Holding AB (publ) American Depositary Shares
OLK
+$10.4M
4
RYZB
RayzeBio, Inc. Common Stock
RYZB
+$10.4M
5
CRWD icon
CrowdStrike
CRWD
+$109K

Sector Composition

Rank Sector Weight
1 Technology 31.65%
2 Healthcare 30.49%
3 Financials 21.22%
4 Consumer Discretionary 16.64%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NU icon
1
Nu Holdings
NU
$73.6B
$76.3M 21.22%
9,155,661
+3,113
+0% +$25.2K
DASH icon
2
DoorDash
DASH
$94B
$59.7M 16.6%
603,288
-224
-0% -$19.8K
PATH icon
3
UiPath
PATH
$8.3B
$57.2M 15.92%
2,303,452
-763,117
-25% -$14.9M
RYZB
4
DELISTED
RayzeBio, Inc. Common Stock
RYZB
$48.4M 13.47%
778,922
-416,667
-35% -$10.4M
SNOW icon
5
Snowflake
SNOW
$114B
$43M 11.95%
215,843
+44
+0% +$7.44K
TXG icon
6
10x Genomics
TXG
$7.31B
$27M 7.5%
481,770
– –
ABOS icon
7
Acumen Pharmaceuticals
ABOS
$193M
$13.1M 3.65%
3,417,075
– –
KVYO icon
8
Klaviyo
KVYO
$5.26B
$13.1M 3.64%
471,260
+1,829
+0.4% +$54.1K
ACRV icon
9
Acrivon Therapeutics
ACRV
$83.6M
$8.13M 2.26%
1,652,605
– –
TARS icon
10
Tarsus Pharmaceuticals
TARS
$3.04B
$5.26M 1.46%
260,000
– –
MASS icon
11
908 Devices
MASS
$414M
$2.66M 0.74%
237,258
– –
SPRB
12
Spruce Biosciences
SPRB
$151M
$2.31M 0.64%
10,493
– –
TSHA icon
13
Taysha Gene Therapies
TSHA
$1.94B
$1.28M 0.36%
724,873
– –
CADL icon
14
Candel Therapeutics
CADL
$897M
$1.19M 0.33%
811,737
– –
ABSI icon
15
Absci
ABSI
$1.58B
$243K 0.07%
57,804
– –
CPNG icon
16
Coupang
CPNG
$29B
$169K 0.05%
10,451
+2,013
+24% +$33.2K
TOST icon
17
Toast
TOST
$20.1B
$144K 0.04%
7,865
+744
+10% +$12.2K
DDOG icon
18
Datadog
DDOG
$91.7B
$123K 0.03%
1,015
-351
-26% -$36.2K
IOT icon
19
Samsara
IOT
$23.2B
$119K 0.03%
3,570
-931,167
-100% -$25.9M
CRWD icon
20
CrowdStrike
CRWD
$221B
$87.8K 0.02%
1,376
-2,084
-60% -$109K
GTLB icon
21
GitLab
GTLB
$7.2B
$41.4K 0.01%
658
– –
CFLT
22
DELISTED
Confluent
CFLT
– –
-1,161
Closed -$34.4K
OLK
23
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
– –
-705,514
Closed -$10.4M

Similar funds

T2I
Turim 21 Investimentos Rio De Janeiro, Brazil $613M AUM 14.25% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $613M AUM 30.37% 1-Year Est. Return
MKA
M. Kulyk & Associates Decatur, Georgia $613M AUM 22.75% 1-Year Est. Return
CSIA
Conrad Siegel Investment Advisors Harrisburg, Pennsylvania $615M AUM 21.19% 1-Year Est. Return
ATFA
All Terrain Financial Advisors Coon Rapids, Minnesota $615M AUM 30.42% 1-Year Est. Return
AA
Aire Advisors Beverly Hills, California $615M AUM 25.07% 1-Year Est. Return
FWM
Fonville Wealth Management Richmond, Virginia $612M AUM 18.82% 1-Year Est. Return
FSA
Financial Security Advisor Virginia Beach, Virginia $615M AUM 26.08% 1-Year Est. Return

Sands Capital Ventures's Q4 2023 Portfolio in Review

As of Q4 2023, Sands Capital Ventures held 23 positions worth $359M, up 6.3% from $338M the previous quarter. Its ten largest holdings account for 98% of the portfolio.

Sands Capital Ventures withdrew a net $61.6M in Q4 2023, closing 2 positions and reducing 6 holdings. Its most notable exit was Olink Holding AB (publ) American Depositary Shares, an estimated $10.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 37% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Sands Capital Ventures added an estimated $54.1K to Klaviyo.

  • Sands Capital Ventures added most to Klaviyo in Q4 2023, an estimated $54.1K increase.
  • Sands Capital Ventures's biggest Q4 2023 reduction was Samsara, cutting an estimated $25.9M.
  • Sands Capital Ventures fully exited Olink Holding AB (publ) American Depositary Shares in Q4 2023, selling an estimated $10.4M.
  • Sands Capital Ventures's ten largest holdings make up 98% of its $359M portfolio in Q4 2023.
  • Sands Capital Ventures opened 0 new positions and closed 2 in Q4 2023.
  • Sands Capital Ventures's portfolio value rose 6.3% quarter-over-quarter to $359M.

Based on Sands Capital Ventures's 13F filing for Q4 2023, filed 13 Feb 2024.